In addition to the MAbs, several laboratories submitted various mycobacterial antigen preparations for testing. These antigens were derived by three different approaches: (i) preparations eluted from MAb immunoadsorbant columns, (ii) an antigen preparation (nonpurified) obtained by recombinant DNA techniques and expressed in Escherichia coli, and (iii) a synthetic peptide prepared by conventional solid-state peptide synthesis methods.
restricted number of additional mycobacteria), and broad cross-reactivity (reacting with a majority of the strains tested). The results for ELISA and RIA were similar for the vast majority of MAbs tested; hence, they were grouped together (with one exception, IT 21). There was substantial variation in the apparent molecular sizes of the antigens recognized by the MAbs (ranging from 12 to 80 kilodaltons [kDa] , with single to multiple bands). However 
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"The IMMTUB MAbs listed are among those described in The low-molecular-weight synthetic peptide (12 amino acids)
did not react in any of the assay systems utilized. Such peptides will probably require polymerization or coupling to a carrier molecule to be effective as immunogens or antigens. The use of these MAbs together with purified mycobacterial antigens should alloW the following questions to be investigated. What is the peptide structure of epitopes recognized by MAbs and T-cell clones? What is the nature of the cell-mediated response(s) elicited in M. bovis BCGvaccinated individuals or tuberculosis patients tested using the purified antigens? These experimehts should be conducted (i) in vitro, using BCG/M. tuberculosis-specific T-cell populations or clones, or (ii) in vivo, either in animal models or in humans, using purified antigens or polymerized peptides as skin test reagents.
Subject to available reserves, samples of the IMMTUB mycobacterium-specific MAbs and the recombinant DNA library will be made available to qualified investigators by the contributing scientists, upon receipt of a short (one page) description summarizing the experiments to be conducted.
